Related references
Note: Only part of the references are listed.Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related Compounds
Oliver Laufkoetter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
The reactome pathway knowledgebase 2022
Marc Gillespie et al.
NUCLEIC ACIDS RESEARCH (2022)
NTRK insights: best practices for pathologists
Jaclyn F. Hechtman
MODERN PATHOLOGY (2022)
Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs
Ruth Nussinov et al.
JOURNAL OF MOLECULAR BIOLOGY (2022)
A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors
Isabel Fernandez-Pisonero et al.
CELL REPORTS (2022)
DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph
Chenye Wang et al.
BMC BIOINFORMATICS (2022)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Emergence of allosteric drug-resistance mutations: new challenges for allosteric drug discovery
Shaoyong Lu et al.
DRUG DISCOVERY TODAY (2020)
CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome
Mark F. Rogers et al.
BIOINFORMATICS (2020)
QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency
Yahya Bokhari et al.
BMC BIOINFORMATICS (2020)
ncdDetect2: improved models of the site-specific mutation rate in cancer and driver detection with robust significance evaluation
Malene Juul et al.
BIOINFORMATICS (2019)
DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies
Yi Han et al.
NUCLEIC ACIDS RESEARCH (2019)
AlloDriver: a method for the identification and analysis of cancer driver targets
Kun Song et al.
NUCLEIC ACIDS RESEARCH (2019)
On the Allosteric Effect of nsSNPs and the Emerging Importance of Allosteric Polymorphism
Wei-Ven Tee et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
Comprehensive Characterization of Cancer Driver Genes and Mutations (vol 173, 371.e1, 2018)
Matthew H. Bailey et al.
CELL (2018)
MaxMIF: A New Method for Identifying Cancer Driver Genes through Effective Data Integration
Yingnan Hou et al.
ADVANCED SCIENCE (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides
Igor V. Kurochkin et al.
BIOCHEMISTRY (2017)
Proteome-Scale Investigation of Protein Allosteric Regulation Perturbed by Somatic Mutations in 7,000 Cancer Genomes
Qiancheng Shen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
Matthew T. Chang et al.
NATURE BIOTECHNOLOGY (2016)
LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer
Giorgio E. M. Melloni et al.
BMC BIOINFORMATICS (2016)
Allostery: An Overview of Its History, Concepts, Methods, and Applications
Jin Liu et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Driver and Passenger Mutations in Cancer
Julia R. Pon et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
Allosite: a method for predicting allosteric sites
Wenkang Huang et al.
BIOINFORMATICS (2013)
DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer
Ali Bashashati et al.
GENOME BIOLOGY (2012)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Accumulation of driver and passenger mutations during tumor progression
Ivana Bozic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cancer as an evolutionary and ecological process
Lauren M. F. Merlo et al.
NATURE REVIEWS CANCER (2006)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
